Kingdon Capital Management, L.L.C. Vertex Pharmaceuticals Inc Transaction History

Kingdon Capital Management, L.L.C.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $17.1 Million - $20.2 Million	-77,300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $13.7 Million - $17.3 Million	77,300 New	77,300 $17 Million
Q1 2018 May 15, 2018	SELL	$151.6 - $177.13 $8.76 Million - $10.2 Million	-57,776 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $3.04 Million - $3.45 Million	22,164 Added 62.24%	57,776 $8.66 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $5.28 Million - $5.78 Million	35,612	35,612 $5.41 Million

1,724

221M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.